Imvotamab Clinical Trials Bispecific Antibodies Market Growth Outlook [Yahoo! Finance]
IGM Biosciences, Inc. (IGMS)
Last igm biosciences, inc. earnings: 3/26 04:05 pm
Check Earnings Report
Company Research
Source: Yahoo! Finance
Delhi, March 17, 2024 (GLOBE NEWSWIRE) -- Global Bispecific Antibody Market Opportunity Insight 2029 Report Highlights: Global Market Forecast Till 2029: USD 36 Billion Approved Bispecific Antibodies: 11 Yearly & Quarterly Sales Insight Global & Regional Sales Insights Insight On Bispecific Antibodies In Clinical Trials: 600 Bispecific Antibodies Global Bispecific Antibodies Clinical Trials By Company, Indication & Phase Fast Track Approval, Orphan Designation & Priority Status Insights Approved Bispecific Antibodies Pricing & Dosage Analysis Top 30 Companies Developing Bispecific Antibodies Competitive Insight 800 Pages Clinical & Commercial Opportunity insight Download Report: https://www.kuickresearch.com/report-bispecific-antibody-market-bispecific-antibodies-market Imvotamab, a pioneering bispecific T cell-engaging IgM antibody, represents a significant breakthrough in the realm of targeted therapy, specifically designed to target both CD20 and CD3 pr
Show less
Read more
Impact Snapshot
Event Time:
IGMS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
IGMS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
IGMS alerts
High impacting IGM Biosciences, Inc. news events
Weekly update
A roundup of the hottest topics
IGMS
News
- IGM Biosciences Insiders Placed Bullish Bets Worth US$992.2k [Yahoo! Finance]Yahoo! Finance
- IGM Biosciences, Inc. (NASDAQ: IGMS) had its "neutral" rating re-affirmed by analysts at HC Wainwright. They now have a $12.00 price target on the stock.MarketBeat
- IGM Biosciences Announces Refocusing of Sanofi Collaboration [Yahoo! Finance]Yahoo! Finance
- IGM Biosciences Announces Refocusing of Sanofi CollaborationGlobeNewswire
- IGM Biosciences to Present at the Stifel 2024 Virtual Targeted Oncology ForumGlobeNewswire
IGMS
Earnings
- 11/13/23 - Beat
IGMS
Sec Filings
- 4/26/24 - Form ARS
- 4/26/24 - Form DEFA14A
- 4/26/24 - Form DEF
- IGMS's page on the SEC website